Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Bavarian Nordic A/S

Capitalization 13.77B 2.12B 1.84B 1.67B 1.59B 2.89B 196B 2.99B 19.82B 7.87B 93.65B 7.97B 7.8B 338B P/E ratio 2026 *
24x
P/E ratio 2027 * 17.4x
Enterprise value 10.09B 1.56B 1.35B 1.22B 1.16B 2.12B 144B 2.19B 14.52B 5.76B 68.61B 5.84B 5.71B 248B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.65x
Free-Float
98.02%
Yield 2026 *
-
Yield 2027 * -
1 day+1.00%
1 week-1.45%
Current month-8.86%
1 month-6.25%
3 months-3.61%
6 months-22.51%
Current year-5.69%
1 week 175.5
Extreme 175.5
187.7
1 month 175.5
Extreme 175.5
198.65
Current year 175.5
Extreme 175.5
202.1
1 year 123.3
Extreme 123.3
244.8
3 years 123.3
Extreme 123.3
300
5 years 115.2
Extreme 115.2
411
10 years 103.2
Extreme 103.2
444
Manager TitleAgeSince
Chief Executive Officer 59 27/05/2014
Director of Finance/CFO 61 31/10/2018
Chief Operating Officer 58 31/03/2022
Director TitleAgeSince
Director/Board Member 63 19/04/2016
Chairman 62 12/11/2025
Director/Board Member 46 31/12/2020
Change 5d. change 1-year change 3-years change Capi.($)
+1.00%-1.45%+9.99%-4.91% 2.12B
-2.26%-0.61%+18.91%+210.22% 873B
-0.39%+1.01%+48.63%+59.65% 583B
-1.01%-3.00%+6.28%+50.54% 398B
+1.73%-5.04%+6.90%+22.61% 324B
+0.47%-0.37%+21.58%+35.19% 297B
+0.57%-1.33%+25.47%+62.77% 294B
-0.26%-0.14%+24.17%+7.63% 287B
-2.61%+0.05%+17.69%+61.40% 198B
-0.54%+0.05%+27.39%+82.65% 180B
Average +0.03%-2.34%+20.70%+58.77% 343.75B
Weighted average by Cap. +0.08%-1.75%+22.95%+88.42%

Financials

2026 *2027 *
Net sales 5.31B 819M 710M 642M 613M 1.12B 75.58B 1.15B 7.64B 3.03B 36.11B 3.07B 3.01B 130B 5.61B 865M 750M 678M 647M 1.18B 79.82B 1.22B 8.07B 3.2B 38.14B 3.24B 3.17B 138B
Net income 479M 73.85M 64.07M 57.93M 55.31M 101M 6.82B 104M 689M 274M 3.26B 277M 271M 11.76B 812M 125M 109M 98.16M 93.72M 170M 11.55B 176M 1.17B 464M 5.52B 470M 460M 19.93B
Net Debt -3.68B -568M -492M -445M -425M -773M -52.41B -800M -5.3B -2.1B -25.04B -2.13B -2.08B -90.38B -4.52B -697M -604M -546M -522M -949M -64.31B -982M -6.5B -2.58B -30.73B -2.61B -2.56B -111B
Logo Bavarian Nordic A/S
Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases. Net sales by revenue source are divided between sales of products (96.1%) and services (3.9%). Net sales are distributed geographically as follows: the United States (47.3%), Germany (17%), Canada (8.6%), France (4.7%), Saudi Arabia (4.6%), Belgium (3.8%), Singapore (2.2%), and other (11.8%).
Employees
1,738
Date Price Change Volume
13/03/26 179.80 kr +1.21% 85,509
12/03/26 177.65 kr -2.98% 402,945
11/03/26 183.10 kr -1.03% 153,186
10/03/26 185.00 kr +1.68% 230,193
09/03/26 181.95 kr -0.38% 248,944
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
177.65DKK
Average target price
268.33DKK
Spread / Average Target
+51.05%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW